Quick Answer
Pulmonx Corp reported Gross Profit of $67.14 million for the year ending 2025.
- Pulmonx Corp showed an increase of +8.3% in Gross Profit from 2024 to 2025.
- This data is from Pulmonx Corp's annual report (Form 10-K), filed with the SEC on March 10, 2026.
- XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2019: $3.72 million | Q2 2019: $4.95 million | Q3 2019: $6.41 million | Q4 2019: $7.34 million | Q1 2020: $5.65 million | Q2 2020: $1.01 million | Q3 2020: $7.46 million | Q4 2020: $7.08 million | Q1 2021: $6.61 million | Q2 2021: $9.03 million | Q3 2021: $9.74 million | Q1 2022: $8.11 million | Q2 2022: $10.42 million | Q3 2022: $10.15 million | Q1 2023: $10.59 million | Q2 2023: $12.73 million | Q3 2023: $13.03 million | Q1 2024: $14.08 million | Q2 2024: $15.31 million | Q3 2024: $15.03 million | Q1 2025: $16.34 million | Q2 2025: $17.20 million | Q3 2025: $16.05 million.
- Over the full 8 years of available data (2018 to 2025), Pulmonx Corp's Gross Profit has grown by 446.5%.
- Historical annual values: Fiscal year 2025: $67.14 million | Fiscal year 2024: $62.00 million | Fiscal year 2023: $50.75 million | Fiscal year 2022: $39.87 million | Fiscal year 2021: $35.63 million | Fiscal year 2020: $21.20 million | Fiscal year 2019: $22.41 million | Fiscal year 2018: $12.29 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: